Atrial Cardiac Organoid

  • Atrial Cardiac Organoid

Human iPSC-derived Atrial Cardiac Organoid

These organoids recapitulate atrial chamber-specific physiology in a 3D structure. They exhibit atrial-like action potentials, atrial-specific gene expression, and functional responses to compounds, enabling mechanistic studies, atrial arrhythmia modeling, and drug screening.

Benefits

  • Atrial-specific phenotype in 3D context
  • Suitable for atrial fibrillation and arrhythmia studies
  • High reproducibility and functional fidelity

Product Specifications

Feature

Detail

Identity Markers

High expression of atrial markers (MLC2a, NPPA, KCNA5), α-actinin alignment

Quantities

≥ 1 × 10⁶ cells per organoid

Quality Control

Electrophysiology (atrial APD), response to atrial-selective drugs, mycoplasma testing

Format

Cryopreserved organoids

Donor & Reprogramming

Healthy or disease-specific donor; Sendai virus reprogramming

Shipping / Storage

Dry shipper at -180°C to -135°C

Supplied with

Organoid medium and detailed instructions

Explore Atrial Cardiac Organoid

Advance your research with our iPSC-derived atrial cardiac organoids, engineered to replicate atrial tissue architecture and functionality. Review the product details to discover how these organoids can support studies in atrial biology, disease modeling, drug screening, and precision cardiac research.

Our Products